The pharmaceutical industry relies on a complex network of chemical intermediates to synthesize life-saving drugs. Among these, 4-Bromomethyl-2-cyanobiphenyl, identified by CAS number 114772-54-2, holds a position of significant importance. At NINGBO INNO PHARMCHEM CO.,LTD., we specialize in the production of such critical compounds, understanding their exact chemical properties and their indispensable role in the synthesis of Sartan-class antihypertensive medications.

Delving into its characteristics, 4-Bromomethyl-2-cyanobiphenyl typically presents as a white to off-white powder, with a high assay of 99.0%min. This level of purity is not merely a specification; it is a prerequisite for its use in pharmaceutical applications, ensuring the safety and efficacy of the final drug product. When companies seek to buy 4-bromomethyl-2-cyanobiphenyl, they are looking for this assurance of quality, which directly translates to the integrity of Sartans drug synthesis. Our manufacturing processes are designed to consistently meet these exacting standards.

The application of this pharmaceutical intermediate CAS 114772-54-2 is primarily in the production of Sartan drugs, a class of medications highly effective in managing hypertension. These drugs work by blocking the action of angiotensin II, a substance in the body that constricts blood vessels. The chemical structure of 4-bromomethyl-2-cyanobiphenyl allows for the precise introduction of necessary functional groups during the multi-step synthesis of these vital APIs. As a reliable China manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. is proud to support the global pharmaceutical market with this essential compound.

The broader impact of this intermediate is felt in public health, as it enables the widespread availability of treatments for a prevalent condition. By providing a consistent and high-quality supply of 4-bromomethyl-2-cyanobiphenyl, we empower pharmaceutical companies to develop and manufacture antihypertensive drugs that improve the quality of life for millions. Our expertise ensures that this building block is readily available for ongoing research and large-scale production needs, solidifying our role as a key contributor to the pharmaceutical supply chain.